22nd Century Group, Inc. is a plant biotechnology company focused on developing and commercializing technologies that allow for the genetic engineering of tobacco and hemp plants. The company?s primary goal is to reduce the harm caused by smoking by developing low-nicotine tobacco products. The company?s products include X-22, a prescription smoking cessation aid, and Moonlight, a low-nicotine cigarette. The company was founded in 1998 and is headquartered in Williamsville, NY.